SWKHL on Nasdaq

SWK Holdings Corp

American miscellaneous business credit institution company. Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with STANDARD PREMIUM FINANCE HOLDINGS, INC. or Troops, Inc. /Cayman Islands/, or pick any stock.

  • TickerSWKHL on Nasdaq1
  • IndustryMiscellaneous Business Credit Institution1
  • HeadquartersDallas, Texas1
  • Incorporated inDE2
  • Business address5956 Sherry Lane, Suite 650, Dallas, Tx 752252
  • Filer categoryNon-accelerated filer, Smaller reporting company2

In addition to historical information, this Annual Report on Form 10-K (“Annual Report”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. From time to time, we may also provide oral or written forward-looking statements in other materials we release to the public. Such forward-looking statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. The forward-looking statements are not historical facts but rather are based on current expectations, estimates and projections about our business and industry, and our beliefs and assumptions, and include, but are not limited to, statements under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Words such as “anticipate,…3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

941.7%Operating margin4
-117.6%Net margin4
-40.5%Revenue growth, 20254
-1.1%Return on equity4
0.14×Debt to equity4
$26.8MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Research and development6¢$1.6M
  • Income tax94¢$22.6M

Out of $2.2M in revenue.4 The company lost money this year.

Where each dollar of operating cash went, fiscal 2025

  • Capital spending2¢$512.0K
  • Share buybacks11¢$3.1M
  • Kept or used elsewhere87¢$23.7M

Out of $27.3M of cash from operations.4

Financial statements

Revenue567894$2.2M in 2025−93% since 2019
0$20.0M$40.0M$60.0M2019: $30.7M$30.7M20192020: $36.7M$36.7M2020+19%2021: $56.2M$56.2M2021+53%2022: $41.5M$41.5M2022−26%2023: $1.2M$1.2M2023−97%2024: $3.6M$3.6M2024+201%2025: $2.2M$2.2M2025−40%
Operating income94$20.3M in 2025+38% since 2023
0$10.0M$20.0M$30.0M2023: $14.7M$14.7M20232024: $11.6M$11.6M2024−21%2025: $20.3M$20.3M2025+75%
Net income567894-$2.5M in 2025
-$10.0M0$10.0M$20.0M$30.0M2019: $23.8M$23.8M20192020: $5.2M$5.2M2020−78%2021: $25.9M$25.9M2021+398%2022: $13.5M$13.5M2022−48%2023: $15.9M$15.9M2023+18%2024: $13.5M$13.5M2024−15%2025: -$2.5M-$2.5M2025

Every line of the income statement as filed: the last 2 fiscal years, latest first.4

Period ending2025-12-312024-12-31
Finance receivable interest income, including fees$38.4M$40.8M
Pharmaceutical development$2.2M$3.6M
Other$865.0K$584.0K
Total revenues$41.5M$45.0M
Provision for (benefit from) credit losses-$924.0K$12.8M
Loss on impairment$641.0K$5.8M
Loss on disposal of inventory$314.0K$0
Interest expense$4.8M$4.7M
Pharmaceutical manufacturing, research and development expense$1.6M$2.2M
Change in fair value of acquisition-related contingent consideration$0-$4.9M
Depreciation and amortization expense$40.0K$1.4M
General and administrative expense$14.8M$11.5M
Income from operations$20.3M$11.6M
Unrealized net gain on warrants$775.0K$2.4M
Net gain on exercise and cancellation of warrants$0$445.0K
Loss on sale of assets-$82.0K$0
Gain on sale of business$1.6M$0
Net loss on marketable investments-$384.0K-$266.0K
Realized gain on early payment of finance receivables$1.7M$1.1M
Gain (loss) on revaluation of finance receivables-$3.7M$2.5M
Realized and unrealized foreign currency transaction gains (losses)-$71.0K$641.0K
Income before income tax expense$20.1M$18.4M
Income tax expense$22.6M$4.9M
Net income (loss)-$2.5M$13.5M
Basic (in dollars per share)-$0.21$1.09
Diluted (in dollars per share)-$0.21$1.09
Basic (in shares)12.2M shares12.4M shares
Diluted (in shares)12.2M shares12.4M shares

Compare SWK Holdings Corp with another company

Leadership

Who has led SWK Holdings Corp, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (33)

Former names

  • KANA SOFTWARE INCNov 29, 2001 to Dec 29, 20092
  • KANA COMMUNICATIONS INCOct 4, 1999 to Apr 10, 20012

Timeline

  1. May 19, 2017New chief executive Winston L. Black Iii. becomes CEO12
  2. May 16, 2012New chief executive James Brett Pope becomes CEO13
  3. Jun 2, 2010New chief executive John Fritzen Nemelka becomes CEO14
  4. Sep 12, 2006New chief executive Michael S. Fields becomes CEO16
  5. Feb 15, 2006New chief executive Chuck Bay becomes CEO15

Filings

261 filings to the SEC since October 2021: 6 annual reports, 13 quarterly reports, 83 major events, 89 insider forms, 13 large holders, 57 other. The latest 20:

  1. Apr 23, 2026SCHEDULE 13G/A EDGAR
  2. Apr 16, 202615-12G EDGAR
  3. Apr 8, 2026EFFECT EDGAR
  4. Apr 8, 2026EFFECT EDGAR
  5. Apr 8, 2026SCHEDULE 13D/A EDGAR
  6. Apr 8, 20264 EDGAR
  7. Apr 7, 2026S-8 POS EDGAR
  8. Apr 7, 2026S-8 POS EDGAR
  9. Apr 7, 2026S-8 POS EDGAR
  10. Apr 7, 2026S-8 POS EDGAR
  11. Apr 7, 2026S-8 POS EDGAR
  12. Apr 7, 2026S-8 POS EDGAR
  13. Apr 7, 2026S-8 POS EDGAR
  14. Apr 7, 2026S-8 POS EDGAR
  15. Apr 7, 2026S-8 POS EDGAR
  16. Apr 7, 2026S-8 POS EDGAR
  17. Apr 7, 2026S-8 POS EDGAR
  18. Apr 7, 2026S-8 POS EDGAR
  19. Apr 7, 2026S-8 POS EDGAR
  20. Apr 7, 2026S-8 POS EDGAR

The 261 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

2 open-market trades by officers, directors and large owners since October 2021: 2 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 9, 2022Staggs Joe David JRPRESIDENTBuy2,745$16.53$45.4KForm 4
Sep 9, 2022Staggs Joe David JRPRESIDENTBuy2,745$16.53$45.4KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54